Naloxone Accord (Naloxone Hydrochloride)

Naloxone Hydrochloride, the active ingredient in Naloxone Accord, is an opioid antagonist presented as a injectable solution for intramuscular and intravenous use. It rapidly reverses life‑threatening respiratory depression caused by opioid overdose in emergency settings. GNH USA supplies Naloxone Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone Accord is an opioid antagonist indicated for conditions involving opioid‑mediated respiratory compromise. - Opioid overdose: rapid reversal of life‑threatening respiratory depression and loss of consciousness. - Opioid‑induced respiratory depression: restores normal breathing in patients receiving opioid analgesia. - Opioid toxicity in emergency care: provides immediate antagonism to prevent fatal outcomes.

Naloxone Accord may cause a range of adverse reactions following administration.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Vomiting: occasional emesis after injection. - Sweating: increased perspiration. - Headache: transient cranial pain. - Agitation: restlessness or anxiety. - Elevated blood pressure: mild rise in systolic pressure.

Serious or Rare Side Effects: - Severe hypertension: marked increase in blood pressure requiring intervention. - Cardiac arrhythmia: irregular heart rhythm. - Pulmonary edema: fluid accumulation in lungs. - Seizures: convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - Acute opioid withdrawal: severe withdrawal symptoms in dependent individuals.

Naloxone Accord should be used with specific safety considerations. - Assess opioid dependence: anticipate possible acute withdrawal symptoms. - Monitor respiratory status: observe for recurrent depression after initial reversal. - Avoid in patients with known hypersensitivity to naloxone or formulation components. - Use with caution in cardiovascular disease: watch for hypertension or arrhythmia. - Store at ambient temperature: keep in original container, protect from moisture and light.

Naloxone may interact with other medications, requiring attention to the level of risk.

Major Interactions (Avoid): - Combined use with potent opioids: can precipitate severe withdrawal. - Use with mixed agonist‑antagonist opioids (e.g., buprenorphine): may reduce efficacy of naloxone.

Moderate Interactions (Monitor Closely): - Concurrent sedatives (benzodiazepines, barbiturates): additive central nervous system depression. - Monoamine oxidase inhibitors (MAOIs): may enhance opioid effects and complicate reversal. - Tricyclic antidepressants: increased risk of cardiac effects when rapid opioid antagonism occurs. - Antihypertensive agents: possible abrupt blood pressure changes after naloxone administration.